A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 732,961 shares of PFE stock, worth $19.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
732,961
Previous 697,507 5.08%
Holding current value
$19.3 Million
Previous $19.5 Million 8.69%
% of portfolio
0.05%
Previous 0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $982,075 - $1.11 Million
35,454 Added 5.08%
732,961 $21.2 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $561,832 - $658,363
-22,242 Reduced 3.09%
697,507 $19.5 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $8.41 Million - $9.66 Million
-324,900 Reduced 31.1%
719,749 $20 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $40,736 - $52,912
-1,559 Reduced 0.15%
1,044,649 $30.1 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $2 Million - $2.34 Million
-62,296 Reduced 5.62%
1,046,208 $34.7 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $2.24 Million - $2.59 Million
61,948 Added 5.92%
1,108,504 $40.7 Million
Q1 2023

May 16, 2023

BUY
$39.39 - $51.28 $17.6 Million - $22.9 Million
446,618 Added 74.44%
1,046,556 $42.7 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $1.53 Million - $2 Million
36,724 Added 6.52%
599,938 $30.8 Million
Q3 2022

Nov 16, 2022

BUY
$43.76 - $53.42 $24.6 Million - $30.1 Million
563,214 New
563,214 $24.6 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $18.4 Million - $22.4 Million
-420,206 Closed
0 $24.6 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $2.98 Million - $3.53 Million
-63,957 Reduced 13.21%
420,206 $22 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $444,781 - $551,140
-9,722 Reduced 1.97%
484,163 $25.1 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $269,695 - $399,778
-6,527 Reduced 1.3%
493,885 $29.2 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $757,564 - $973,156
-19,301 Reduced 3.71%
500,412 $21.5 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $441,369 - $499,997
12,291 Added 2.42%
519,713 $20.4 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $5.96 Million - $6.72 Million
177,837 Added 53.96%
507,422 $18.4 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $242,724 - $308,645
7,252 Added 2.25%
329,585 $12.1 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $4.57 Million - $5.36 Million
144,011 Added 80.76%
322,333 $11.8 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $3.35 Million - $4.06 Million
111,233 Added 165.8%
178,322 $5.83 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $523,354 - $747,760
19,362 Added 40.57%
67,089 $2.19 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $551,245 - $625,593
16,745 Added 54.05%
47,727 $1.87 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $395,175 - $512,427
12,163 Added 64.63%
30,982 $1.11 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $359,630 - $403,782
9,725 Added 106.94%
18,819 $815,000
Q1 2019

Jun 12, 2019

SELL
$37.5 - $41.2 $9,262 - $10,176
-247 Reduced 2.64%
9,094 $386,000
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $350,287 - $384,849
9,341 New
9,341 $397,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.